Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals)

v3.6.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($)
3 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Research and Development Expense [Member]    
Non-cash Stock Option Compensation Expenses $ 79,700 $ 18,946
Selling and Marketing Expense [Member]    
Non-cash Stock Option Compensation Expenses $ 180,037 $ 93,549